The silent change: What to expect when going through perimenopause
BIG READ: Dr Linda Dear labels perimenopause a "blind spot".
AdvertisementAdvertise with NZME.
Latest fromPharmaceuticals
'Tour de force' in heritage restoration wins Property Council award
Sensitive refurbishment and amalgamation of the buildings takes prize.
How a generation of men got hooked on anti-hair loss drugs
Telegraph: Jack Rear started taking finasteride even though he wasn't sure he needed it.
Is a revolution in cancer treatment within reach?
New York Times: Once-deadly diseases are now survivable, writes Kate Pickert.
She lost 40kg on a new diet drug. Her friends melted away too
New York Times: Katarra Ewing's experience isn't uncommon, obesity experts say.
What you need to know about the pill – before your daughter takes it
Telegraph: A new doco casts an unflattering light on reproductive healthcare for women.
Australians, Brits to get free prescriptions in NZ
NZ has reciprocal health agreements with the UK and Oz, National not impressed.
A prescription for better access to medicine
Opinion: Barriers remain after $5 co-payment charge is gone.
Top diet doctor shares his weight-loss tips in the age of Ozempic
Telegraph: Drugs won't solve the world's obesity problem, says Professor Roy Taylor.
Some prescriptions will still attract $15 fee, despite Budget policy to abolish $5 charges
The Government has abolished most charges, but some remain.
'Huge help': Bay pharmacists praise decision to abolish $5 prescription fee
The decision, announced as part of Budget 2023, will cost the Government $619m.
Medsafe suspends Pharmacy 44's operating licences
Medsafe says an audit found a "significant number of non-compliance issues".
'Would they run out of Viagra?' Pharmac slammed for huge shortage of HRT
Northland women going through menopause are starting to suffer due to an HRT shortage.
Before you consider a weight-loss drug, read this
Telegraph: Here's everything you need to know about the new anti-fat injections.
Two Alzheimer’s drugs offer hope to patients after decades of waiting
Financial Times: Trial results are impressive, but some experts remain sceptical.
Alzheimer’s breakthrough: How to spot the early signs of dementia
Telegraph: A groundbreaking new drug slows symptoms, but early detection is still key.
Desperate for a good night’s sleep? Before you take a pill, read this
Telegraph: Insomnia is a growing problem. Here's what you need to know about treatments.
'A real physical phenomenon': New obesity drug set to upend weight loss
Fast-track approval sought for drug that helps shed up to 20 per cent of body weight.
The skinny on Ozempic - the wonder injection poised to blow diet industry apart
Telegraph: Diet giants like WW are scrambling to adjust as new drugs change the game.
Will Kiwi breakthrough drug for Rett Syndrome make history?
NZ drug to help hundreds of thousands of girls and women worldwide awaits FDA approval.
'Lagging behind': Bay doctor starts petition for more menopausal hormone therapy options
Since its launch last month, the petition has gained more than 3300 signatures.
Opinion: Is big pharma profiteering from the pandemic?
OPINION: Investigations allege cancelled vaccine orders are still being paid for.
US approves drug that slows Alzheimer's
Leqembi is the first drug that’s been convincingly shown to slow the decline in memory.
Fire and ice: Five big questions Kiwi researchers want to answer
Can cannabinoids treat pain? Where do our eels spawn? We highlight five new Kiwi studies.
US clears updated Covid-19 vaccines for children under age 5
Food and Drug Administration aims to better protect the youngest from severe Covid.
Cystic fibrosis drug win, serious police incident in West Akl & Iran to disband oppressive morality police | Focus Morning Bulletin 5 December, 2022
Huge win for those with cystic fibrosis, police staff involved in West Auckland 'serious incident' & Iran to disband morality police amid ongoing protests in the latest New Zealand Herald headlines. Video / NZ Herald
Cystic fibrosis: Funding of life-extending drug Trikafta proposed to start in April
Funding of Trikafta will be for those aged 6 and older who meet certain criteria.
New drug slows Alzheimer’s but can it make a real difference?
It's a bright spot after repeated disappointments in the quest for better treatments.
Kiwi scientists develop world’s first algae-based pain medication
Hopes that discovery is a non-addictive alternative to opioids.
'Cruel and heartless': $52k annual tax on 'miracle drug' slammed
'We will do anything to keep our boy alive but ... detest having to pay tax to do so.'
'We still wait, and die, for our miracle drug - why?'
OPINION: 'Trikafta makes cystic fibrosis a manageable condition. It lets people live.'
Douglas Pharmaceuticals' new $50m block opens
Hi-tech lab and skybridge in major new R&D site.
US pharmacy chains fined $1b over opioid crisis in communities
Jury says pharmacies played a massive role in creating a public nuisance.
Rua Bioscience CEO Rob Mitchell to retire
Rua director Anna Stove will lead the business as managing director.